Funds Benchmark
Funds in our coverage with Eli Lilly and Company among their ten largest positions, with about £19.5B of those funds’ assets in it. FE fundinfo data, to 31 Oct 2026.
| 5Y | Volatility | Quartile | ||||||
|---|---|---|---|---|---|---|---|---|
| iShares S&P 500 Health Care Sector UCITS ETFBlackRock | Passive | 15.15% | +28.3% | Pro | Pro | 0.15% | £2.2B | Free account |
| State Street Health Care Select Sector SPDR ETFSPDR ETFs | Passive | 15.13% | +27.8% | Pro | Pro | 0.08% | £31.2B | Free account |
| Xtrackers MSCI USA Health Care UCITS ETFDWS | Passive | 15.07% | +22.2% | Pro | Pro | 0.12% | £661.1M | Free account |
| iShares U.S. Healthcare ETFBlackRock | Passive | 14.55% | +25.6% | Pro | Pro | 0.44% | n/a | Free account |
| Fidelity MSCI Health Care Index ETFFidelity | Passive | 13.35% | +28.1% | Pro | Pro | n/a | n/a | Free account |
| Worldwide Healthcare Trust PLCFrostrow Capital LLP | Not classified | 11.80% | +17.8% | Pro | Pro | 0.90% | £1.4B | Free account |
| Legal & General Global Health and Pharmaceuticals Index TrustLegal & General | Passive | 11.20% | +19.2% | Pro | Pro | 0.69% | £1.1B | Free account |
| Xtrackers MSCI World Health Care UCITS ETFDWS | Passive | 11.04% | +20.7% | Pro | Pro | 0.25% | £2.8B | Free account |
| iShares MSCI World Health Care Sector Advanced UCITS ETFBlackRock | Passive | 10.75% | +18.1% | Pro | Pro | 0.18% | £718.2M | Free account |
| Health Care InnovatorsBNP PARIBAS ASSET MANAGEMENT | Active | 9.53% | +11.0% | Pro | Pro | 1.96% | £1.3B | Free account |
| World Healthscience FundBlackRock | Active | 9.46% | +19.8% | Pro | Pro | 1.81% | £10.4B | Free account |
| International Health Care PortfolioAllianceBernstein | Active | 9.44% | +21.0% | Pro | Pro | 0.51% | £2.7B | Free account |
| Bellevue Sustainable HealthcareBellevue Asset Management | Active | 9.35% | +7.2% | Pro | Pro | 2.18% | £55.1M | Free account |
| Wellington Global Health Care Equity FundWellington | Active | 9.33% | +25.7% | Pro | Pro | 0.84% | £872.7M | Free account |
| Global Life Sciences FundJanus Henderson Investors | Active | 9.25% | +22.7% | Pro | Pro | 0.89% | £4.1B | Free account |
| Global Healthcare FundFidelity | Active | 8.66% | +5.4% | Pro | Pro | 2.65% | £945.5M | Free account |
| Healthcare Opportunities FundPolar Capital | Active | 7.84% | +3.7% | Pro | Pro | 1.58% | £1.7B | Free account |
| Global Healthcare FundJ.P. Morgan Asset Management | Active | 7.80% | +15.2% | Pro | Pro | 1.81% | £2.5B | Free account |
| First Trust Nasdaq Pharmaceuticals ETFFirst Trust | Passive | 7.77% | +48.4% | Pro | Pro | n/a | n/a | Free account |
| Tareno Sustainable Healthcare FundTareno | Active | 7.60% | +11.8% | Pro | Pro | 0.92% | £139.2M | Free account |
| Pru FRIA AXA Framlington Health PnPru | Not classified | 7.21% | n/a | Pro | Pro | n/a | £469K | Free account |
| Candriam Equities L OncologyCandriam | Active | 6.65% | +25.0% | Pro | Pro | 1.94% | £1.2B | Free account |
| CastleArk Large Growth ETFCastleArk | Passive | 5.46% | n/a | Pro | Pro | n/a | n/a | Free account |
| RiverPark Long/Short Opportunity FundRiverPark | Not classified | 5.27% | +2.1% | Pro | Pro | n/a | n/a | Free account |
| J.P. Morgan Mansart MSCI Canada FundJ.P. Morgan Mansart Management | Passive | 4.87% | +16.7% | Pro | Pro | 0.50% | £1.1B | Free account |
| Global Equity Sustainable HealthcareHSBC | Active | 4.84% | +10.7% | Pro | Pro | 1.10% | £222.6M | Free account |
| Us Equity Fundamental GrowthAmundi | Active | 4.65% | −3.6% | Pro | Pro | 0.86% | £2.2B | Free account |
| US SELECT GrowthEdgewood L Select | Active | 4.52% | −14.8% | Pro | Pro | 1.92% | £1.2B | Free account |
| AMCAPCapital | Not classified | 4.41% | n/a | Pro | Pro | n/a | £72.5B | Free account |
| US High Profitability ETFDimensional | Passive | 4.40% | n/a | Pro | Pro | 0.19% | n/a | Free account |
| apo Medical OpportunitiesIPConcept | Active | 4.39% | +12.6% | Pro | Pro | 1.76% | £554.6M | Free account |
| NYLI U.S. Large Cap R&D Leaders ETFIndex IQ | Passive | 4.23% | n/a | Pro | Pro | n/a | n/a | Free account |
| WisdomTree BioRevolution FundWisdomTree | Not classified | 4.08% | +58.5% | Pro | Pro | n/a | n/a | Free account |
| ARK Genomic Revolution ETFARK Invest | Active | 3.96% | +97.8% | Pro | Pro | n/a | n/a | Free account |
| Allianz Global Artificial IntelligenceAllianz Global Investors | Active | 3.94% | +26.8% | Pro | Pro | 1.10% | £6.6B | Free account |
| iShares Future Exponential Technologies ETFBlackRock | Passive | 3.92% | +17.8% | Pro | Pro | 0.47% | n/a | Free account |
| Capital Group Core Equity ETFCapital Advisors | Passive | 3.68% | n/a | Pro | Pro | n/a | n/a | Free account |
| iShares MSCI USA Quality Factor ETFBlackRock | Passive | 3.66% | +17.3% | Pro | Pro | 0.15% | n/a | Free account |
| Julius Baer Global Excellence EquityThree Rock Capital Management | Active | 3.54% | +1.3% | Pro | Pro | 1.47% | £2.4B | Free account |
| VanEck MSCI International Quality ETFVanEck | Passive | 3.52% | +17.1% | Pro | Pro | 0.40% | n/a | Free account |
| UBS Factor MSCI USA Quality Screened UCITS ETFUBS | Passive | 3.45% | +10.4% | Pro | Pro | 0.28% | £842.5M | Free account |
| US Forty FundJanus Henderson Investors | Active | 3.41% | +7.3% | Pro | Pro | 2.17% | £1.1B | Free account |
| T. Rowe Price Growth Stock ETFT.Rowe Price | Passive | 3.41% | n/a | Pro | Pro | n/a | n/a | Free account |
| Xtrackers MSCI USA ESG UCITS ETFDWS | Passive | 3.41% | +3.9% | Pro | Pro | 0.20% | £7.0B | Free account |
| UBS MSCI USA Climate Paris Aligned UCITS ETFUBS | Passive | 3.39% | +15.7% | Pro | Pro | 0.09% | £98.6M | Free account |
| DJE - Dividende & SubstanzDJE Investment | Active | 3.27% | +10.5% | Pro | Pro | 1.67% | £1.2B | Free account |
| Amundi Smart Overnight ReturnAmundi | Passive | 3.19% | +2.2% | Pro | Pro | 0.09% | £16.4B | Free account |
| iShares Paris-Aligned Climate MSCI USA ETFBlackRock | Passive | 3.09% | +11.0% | Pro | Pro | n/a | n/a | Free account |
| American MutualCapital | Not classified | 3.08% | n/a | Pro | Pro | n/a | £83.9B | Free account |
| Mirova Global Sustainable EquityNatixis Investment Managers | Active | 3.07% | +5.4% | Pro | Pro | 0.81% | £4.3B | Free account |
Weight is the share of each fund in this company. Returns are GBP, to month end. FE quartile compares a fund with its FE sector over the same year. Fund size is in GBP. Source: FE fundinfo. Past performance is not a reliable guide to future returns.
The Dow Jones fell 1,833 points (3.44%) to close at 51,523 on November 6, led by declines in Nvidia (-9.23%), Cisco (-7.62%), and Goldman Sachs (-6.42%) as chip concerns persisted.
US midterm elections took place with broader market implications amid uncertainty about fiscal policy and geopolitical developments including Iran war impacts.
Early projections pointed to a Democratic victory in the US midterm elections, with Democrats gaining control of Congress. This reduced political uncertainty regarding the Trump administration's fiscal policy.
The Dow Jones jumped 1,569 points (3.03%) to 53,356, the S&P 500 added 1.58% to 7,688, and the Nasdaq gained 1.44% on November 4 following Democratic election victory and falling energy prices.
Private sector employment increased by 86,000 jobs in October, exceeding market expectations of 69,000 and matching September's revised gain.
Democrats secured control of both the Senate and House in the November 3, 2026 midterm elections, reducing geopolitical conflict uncertainty and leading to sharp market rallies, particularly in sectors benefiting from...
Available job positions rose 333,000 to 7.52 million in September, exceeding all economist estimates and signaling firmer demand for workers heading into Q4.
The Nasdaq Composite dropped 2% on Friday with the S&P 500 down 0.9% and Dow down 0.6% for the week as investors dumped tech stocks amid AI spending scrutiny and election uncertainty.
The October 2026 employment report showed 182,000 jobs added with unemployment stable at 4.1%, indicating continued labor market strength above breakeven pace.
U.S. stock indices fell on October 29-30, with S&P 500 down 0.91%, Nasdaq sliding 1.4%, amid renewed concerns about the sustainability of the AI trade following disappointing results from major technology companies.
First estimate of third-quarter U.S. GDP and September PCE inflation data released simultaneously, providing key economic growth and pricing information before year-end.
The Federal Reserve announced its rate decision on October 28 at 2:00 PM ET, widely expected to hold rates steady at 3.75%-4.00% following September's 25-basis-point increase, with markets pricing 90% probability of n...
Counts events recorded in our market events log, not news volume. Information only, not advice.
Source: FE fundinfo. Holdings are each fund’s ten largest positions as reported, so a fund can have more of this company than shown or none at all. Returns are GBP to month end unless stated. Past performance is not a reliable guide to future returns. Capital is at risk. Information only, not advice or a recommendation.
Cookie settings
Choose which cookies we may use. Essential cookies are always on because the site needs them to work. Analytics cookies are off until you turn them on. Cookieless page-view signals to Google Analytics are sent before you choose and if you reject; they set no cookies. Read the privacy notice
